Scientists have developed a male contraceptive that doesnโt target testosterone, avoiding unwanted side effects like weight gain and depression. After proving 99% effective at preventing pregnancy in mice, the drug is set for human trials.
It looks as though birth control options for men may soon expand beyond condoms and vasectomies because scientists in the US have developed a male contraceptive pill thatโs so far proven safe and effective on mice.
Set for clinical trials in humans as early as this year, the drugโs approval could help to balance the burden thatโs currently placed on those who ovulate.
The news is particularly welcome in the UK amid recent allegations that the countryโs heavily understaffed and underfunded reproductive healthcare services are unable to perform IUD removals, leaving thousands of women in extreme discomfort.
Presenting their findings at the American Chemical Societyโs Spring 2022 conference last Tuesday, researchers explained that the breakthrough medication works thanks to a molecule called YCT529.
Targeting a protein called the retinoic acid receptor alpha (RAR-ฮฑ) โ a form of vitamin A that plays an important role in sperm formation โ itโs able to cause a significant reduction in sperm count over a four-week period.
Within a month of being weaned off the pill, fertility levels return to normal, and reproduction becomes possible once more.
https://twitter.com/groomrlady/status/1507546856548618242
What makes the discovery stand out, however, is that the pill does not target testosterone (the male sex hormone), thereby eliminating the risk of side effects that have, until now, kept previous alternatives from landing on the shelves of pharmacies across the globe.